Summary of Purpose
The time window for intravenous recombinant tissue plasminogen activator treatment in ischemic stroke patients has been extended to 4.5h. Little is known about intravenous recombinant tissue plasminogen activator use in the 3-4.5 hour time window among Chinese stroke patients. This exploratory study was to describe the feasibility and outcome of treatment with intravenous recombinant tissue plasminogen activator...Read More →
The following dates are available for this trial. Trial information last updated on 9 December 2014.
|1 Jan 2008||8 Jan 2013||1 Dec 2014||1 Dec 2014||1 Dec 2014||Unavailable|
|Start Date||First Received||1st Completion||Completion||Verification||Results|
- Observation: Case Control
- Perspective: Prospective
- Sampling: Probability Sample